
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1253
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT01282476 | Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
NCT03075527 | A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma | ||
NCT04879927 | Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement | ||
NCT00095927 | Randomized Amifostine For SCCHN | ||
NCT06328127 | Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors | ||
NCT02390427 | Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer | ||
NCT05349227 | Comprehensive Outcomes for After Cancer Health | ||
NCT01177527 | Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders | ||
NCT05643027 | A Novel Intervention for Patients With Cancer | ||
NCT00157573 | GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer | ||
NCT00476476 | Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar | ||
NCT00006127 | Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia | ||
NCT01562873 | Ruxolitinib in Patients With Breast Cancer | ||
NCT02956473 | Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy | ||
NCT03203473 | Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) | ||
NCT04965792 | Post-treatment Surveillance in HPV+ Oropharyngeal SCC | ||
NCT05535192 | TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients | ||
NCT01415492 | Multiple Risk Behavior Intervention in Health Care Settings | ||
NCT00545792 | Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | ||
NCT03865589 | Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome | ||
NCT02523040 | A Study of Lenalidomide for Adult Histiocyte Disorders | ||
NCT03824860 | Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study | ||
NCT02036476 | Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma | ||
NCT00673127 | Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer | ||
NCT01188876 | Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer | ||
NCT01112527 | PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma | ||
NCT00005627 | Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | ||
NCT03364673 | Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer | ||
NCT01746173 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | ||
NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | ||
NCT01472627 | Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro | ||
NCT00047294 | Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
NCT00593060 | Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer | ||
NCT04708860 | Feasibility of Fasting & Exercise in Pts With HR+ MBC | ||
NCT00525460 | Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function | ||
NCT03761160 | Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy | ||
NCT04299191 | Study of LAM561 Acid in Pediatric Patients with Malignant Glioma and Other Advanced Solid Tumors | ||
NCT00776594 | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | ||
NCT01647594 | Pilot Study for Young Women's Intervention | ||
NCT00251394 | Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma | ||
NCT04781062 | Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer | ||
NCT02337491 | Pembrolizumab +/- Bevacizumab for Recurrent GBM | ||
NCT00482391 | Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer | ||
NCT02871791 | Palbociclib With Everolimus + Exemestane In BC | ||
NCT00139191 | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | ||
NCT03391362 | Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases | ||
NCT02823262 | A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older | ||
NCT00483262 | Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma | ||
NCT04356729 | A Phase II Trial of PD-L1 Therapy Combined with Anti-VEGF Therapy in Unresectable or Metastatic Melanoma | ||
NCT00142129 | Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia |